Skip to content

Enveric Biosciences, Inc.

ENVB

CIK 0000890821

← back to feed
Revenue (TTM)
$36.9M
−7.2% YoY Q1 May 2026
Net Income (TTM)
−$8.21M
+8.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$27.44
+84.1% YoY Q1 May 2026
Gross Margin
20.3%
Q1 May 2026
Operating Margin
-22.3%
Q1 May 2026
Net Margin
-22.3%
Q1 May 2026
Free Cash Flow (TTM)
−$12.39M
Q1 May 2026
Cash
$2.84M
Q1 May 2026
Total Debt
$1M
Q1 May 2026
Shares Outstanding
3.68M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings